Literature DB >> 26901454

Is anti-Müllerian hormone associated with IVF outcomes in young patients with diminished ovarian reserve?

Nigel Pereira1, Robert Setton2, Allison C Petrini2, Jovana P Lekovich1, Rony T Elias1, Steven D Spandorfer1.   

Abstract

AIM: To investigate whether anti-Müllerian hormone (AMH) is associated with IVF cycle outcomes in young patients with diminished ovarian reserve. MATERIALS &
METHODS: Retrospective study of patients <35 years of age undergoing fresh IVF who had at least two 8-cell, day-3 embryos transferred with grades 1, 1.5 or 2. Patients were subgrouped, a priori, based on serum AMH levels: <1 or >1 ng/ml and <0.5 or >0.5 ng/ml.
RESULTS: In total, 1005 patients were included. Patients in the >1 ng/ml group required lesser gonadotropins compared with the <1 ng/ml and the <0.5 ng/ml group. More oocytes were retrieved from the same group compared with the latter two (p < 0.001). Despite these differences, the overall rates of clinical pregnancy, spontaneous abortion and live birth were comparable between the two groups.
CONCLUSION: In patients with diminished ovarian reserve who have good quality embryos, AMH is not associated with clinical pregnancy, spontaneous miscarriage or live birth rates.

Entities:  

Keywords:  IVF; anti-Müllerian hormone; diminished ovarian reserve; outcomes; prediction

Mesh:

Substances:

Year:  2016        PMID: 26901454      PMCID: PMC5375045          DOI: 10.2217/whe.15.102

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  33 in total

1.  Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve.

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Fertil Steril       Date:  2010-06-11       Impact factor: 7.329

2.  Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

Authors:  Jesper M J Smeenk; Fred C G J Sweep; Gerhard A Zielhuis; Jan A M Kremer; Chris M G Thomas; Didi D M Braat
Journal:  Fertil Steril       Date:  2006-11-01       Impact factor: 7.329

3.  Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function.

Authors:  David H Barad; Andrea Weghofer; Norbert Gleicher
Journal:  Fertil Steril       Date:  2009-02-12       Impact factor: 7.329

Review 4.  Developmental and endocrine aspects of normal ovarian aging.

Authors:  E R te Velde; G J Scheffer; M Dorland; F J Broekmans; B C Fauser
Journal:  Mol Cell Endocrinol       Date:  1998-10-25       Impact factor: 4.102

Review 5.  A systematic review of tests predicting ovarian reserve and IVF outcome.

Authors:  F J Broekmans; J Kwee; D J Hendriks; B W Mol; C B Lambalk
Journal:  Hum Reprod Update       Date:  2006-08-04       Impact factor: 15.610

6.  Anti-Müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation.

Authors:  Ryan Riggs; Thomas Kimble; Sergio Oehninger; Silvina Bocca; Yueqin Zhao; Ben Leader; Laurel Stadtmauer
Journal:  Fertil Steril       Date:  2010-08-23       Impact factor: 7.329

7.  Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.

Authors:  Sesh Kamal Sunkara; Vivian Rittenberg; Nick Raine-Fenning; Siladitya Bhattacharya; Javier Zamora; Arri Coomarasamy
Journal:  Hum Reprod       Date:  2011-05-10       Impact factor: 6.918

8.  Determining an anti-Mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve.

Authors:  Zaher Merhi; Athena Zapantis; Dara S Berger; Sangita K Jindal
Journal:  J Assist Reprod Genet       Date:  2013-08-21       Impact factor: 3.412

9.  Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.

Authors:  Joan-Carles Arce; Antonio La Marca; Bjarke Mirner Klein; Anders Nyboe Andersen; Richard Fleming
Journal:  Fertil Steril       Date:  2013-02-05       Impact factor: 7.329

10.  The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age.

Authors:  Robert K K Lee; Frank S Y Wu; Ming-Huei Lin; Shyr-Yeu Lin; Yuh-Ming Hwu
Journal:  Reprod Biol Endocrinol       Date:  2011-08-15       Impact factor: 5.211

View more
  3 in total

1.  Antimüllerian hormone as a risk factor for miscarriage in naturally conceived pregnancies.

Authors:  Brianna M Lyttle Schumacher; Anne Marie Z Jukic; Anne Z Steiner
Journal:  Fertil Steril       Date:  2018-06-02       Impact factor: 7.329

2.  Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle.

Authors:  Xin Liu; Ying Han; Xinyan Wang; Yunshan Zhang; Aijun Du; Ruqiang Yao; Jiabei Lv; Haining Luo
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-02       Impact factor: 3.105

3.  Which Factors Are Associated With Reproductive Outcomes of DOR Patients in ART Cycles: An Eight-Year Retrospective Study.

Authors:  Lu Li; Bo Sun; Fang Wang; Yile Zhang; Yingpu Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.